COVID-19 as a potential trigger of complement-mediated atypical HUS

Affiliations

• ¹ Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service d'Immunologie, Paris, France.
• ² Paris University, Paris, France.
• ³ Department of Nephrology-Intensive Care, University Hospital, Dijon, France.
• ⁴ Department of Nephrology and Transplantation, Amiens University Hospital, Amiens, France.
• ⁵ Hôpitaux de Marseille, CHU de la Conception, Service de Médecine Interne et immunologie clinique, Marseille, France.
• ⁶ Assistance Publique-Hôpitaux de Marseille (AP-HM), Aix-Marseille Université and C2VN, Inserm U1263, Inrae 1260, Marseille, France.
• ⁷ Transplantation Center, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
• ⁸ Hôpitaux de Marseille, Centre de Néphrologie et Transplantation Rénale, CHU de la Conception, Marseille, France.
• ⁹ Service de Néphrologie, Dialyse et Transplantation, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris (AP-HP), Le Kremlin-Bicêtre, France.
• ¹⁰ Service d'Anatomie Pathologique, Hôpital de La Timone, AP-HM, Aix-Marseille Université, Marseille, France.
• ¹¹ Service of Immunology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
• ¹² Service of Clinical Pathology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
• ¹³ Inflammation, Complement and Cancer Team, Cordeliers Research Center, INSERM Unité Mixte de Recherche (UMR) S1138, Paris, France; and.
• ¹⁴ Service of Nephrology and Hypertension, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.